## WHO Classification of Xerophthalmia Stages **Key Point:** The WHO classification defines xerophthalmia progression in a specific sequence that reflects the pathophysiology of vitamin A deficiency. ### Stage-wise Progression | Stage | Clinical Finding | Reversibility | |-------|------------------|----------------| | XN | Night blindness (earliest sign) | Fully reversible | | X1A | Conjunctival xerosis | Fully reversible | | X1B | Bitot's spots (foamy appearance) | Fully reversible | | X2 | Corneal xerosis (hazy cornea) | Fully reversible | | X3A | Corneal ulceration/melting (< 1/3 cornea) | Partially reversible | | X3B | Corneal scarring (≥ 1/3 cornea) | Irreversible | | XS | Corneal scar (end-stage) | Irreversible | **High-Yield:** Night blindness (XN) is the **earliest clinical sign** of vitamin A deficiency because retinol is essential for rhodopsin synthesis in rod cells. It appears before any structural changes to the conjunctiva or cornea. **Mnemonic:** **N-C-C-S** = Night blindness → Conjunctival changes → Corneal changes → Scarring (irreversible) **Clinical Pearl:** Bitot's spots (foamy, triangular patches on temporal conjunctiva) are pathognomonic for xerophthalmia but appear after night blindness. They represent desquamated epithelium and are reversible with vitamin A supplementation. ### Why This Sequence Matters 1. **XN (Night blindness)** — Rod dysfunction; no structural damage yet 2. **X1A/X1B (Conjunctival xerosis)** — Loss of mucin-secreting goblet cells; Bitot's spots appear 3. **X2 (Corneal xerosis)** — Corneal epithelium becomes hazy; still reversible 4. **X3A/X3B (Corneal scarring)** — Irreversible damage; risk of permanent blindness **Warning:** Corneal involvement (X2 onwards) requires urgent vitamin A therapy to prevent irreversible blindness. A dose of 200,000 IU is given on days 1, 2, and 14 in children with corneal involvement. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.